Search Page

1

Cite

Share

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms.

Sahin IH, Akce M, Alese O, Shaib W, Lesinski GB, El-Rayes B, Wu C. Sahin IH, et al. Br J Cancer. 2019 Nov;121(10):809-818. doi: 10.1038/s41416-019-0599-y. Epub 2019 Oct 14. Br J Cancer. 2019. PMID: 31607751 Free PMC article. Review.

Cite

Share

2

Cite

Share

Regorafenib, an investigational agent for the treatment of cholangiocarcinoma.

Sahin IH, Tan E, Kim R. Sahin IH, et al. Expert Opin Investig Drugs. 2021 Apr;30(4):333-341. doi: 10.1080/13543784.2021.1867537. Epub 2020 Dec 30. Expert Opin Investig Drugs. 2021. PMID: 33378249 Review.

Cite

Share

3

Cite

Share

Pancreatic cancer microenvironment: a current dilemma.

Uzunparmak B, Sahin IH. Uzunparmak B, et al. Among authors: sahin ih. Clin Transl Med. 2019 Jan 15;8(1):2. doi: 10.1186/s40169-019-0221-1. Clin Transl Med. 2019. PMID: 30645701 Free PMC article. Review.

Cite

Share

4

Cite

Share

Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?

Sahin IH, Askan G, Hu ZI, O'Reilly EM. Sahin IH, et al. Ann Oncol. 2017 Dec 1;28(12):2950-2961. doi: 10.1093/annonc/mdx503. Ann Oncol. 2017. PMID: 28945842 Free PMC article. Review.

Cite

Share

5

Cite

Share

Neoadjuvant and adjuvant treatment approaches for hepatocellular carcinoma: future outlook.

Sahin IH, Khalil L, Millett R, Kaseb A. Sahin IH, et al. Chin Clin Oncol. 2021 Feb;10(1):7. doi: 10.21037/cco-20-248. Epub 2021 Jan 11. Chin Clin Oncol. 2021. PMID: 33440948 Free article.

Cite

Share

6

Cite

Share

Precision medicine for metastatic colorectal cancer: an evolving era.

Guler I, Askan G, Klostergaard J, Sahin IH. Guler I, et al. Among authors: sahin ih. Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):919-931. doi: 10.1080/17474124.2019.1663174. Epub 2019 Sep 3. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31475851 Review.

Cite

Share

7

Cite

Share

Molecular Profiling of Pancreatic Cancer Patients-Letter.

Sahin IH, Elias H. Sahin IH, et al. Clin Cancer Res. 2018 Dec 15;24(24):6611. doi: 10.1158/1078-0432.CCR-18-2255. Clin Cancer Res. 2018. PMID: 30552236 No abstract available.

Cite

Share

8

Cite

Share

Precision medicine for gastrointestinal cancers: a conference report.

Sahin IH. Sahin IH. Future Sci OA. 2020 May 27;6(6):FSO478. doi: 10.2144/fsoa-2020-0061. Future Sci OA. 2020. PMID: 32670606 Free PMC article.

Cite

Share

9

Cite

Share

BRAF Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues.

Sahin IH, Klostergaard J. Sahin IH, et al. JCO Oncol Pract. 2021 Dec;17(12):723-730. doi: 10.1200/OP.21.00160. Epub 2021 Jun 2. JCO Oncol Pract. 2021. PMID: 34077235 Review.

Cite

Share

10

Cite

Share

Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA.

Huang J, Soupir AC, Schlick BD, Teng M, Sahin IH, Permuth JB, Siegel EM, Manley BJ, Pellini B, Wang L. Huang J, et al. Among authors: sahin ih. Cancers (Basel). 2021 Nov 9;13(22):5611. doi: 10.3390/cancers13225611. Cancers (Basel). 2021. PMID: 34830765 Free PMC article.

Cite

Share